MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Net loss-$60,606K (6.27%↑ Y/Y)Income tax benefit-$131K Loss beforeprovision for income taxes-$60,737K (6.07%↑ Y/Y)Health Care SpecialtyPharmacy$269,176K Health Care PatientService$228,991K (11.77%↑ Y/Y)Clinical Research TrialsAnd Other Revenue$4,562K (-47.03%↓ Y/Y)Loss from operations-$36,083K (39.98%↑ Y/Y)Total othernon-operating expense-$24,654K (-442.44%↓ Y/Y)Total operatingrevenue$502,729K (27.79%↑ Y/Y)Total operatingexpenses$538,812K (18.80%↑ Y/Y)Change in fair value ofconversion option...-$12,206K (-552.58%↓ Y/Y)Interest expense, net$11,276K (50.43%↑ Y/Y)Other, net-$925K (-153.42%↓ Y/Y)Change in fair value ofderivative warrant...$247K (139.90%↑ Y/Y)Direct costs-HealthCare Specialty...$220,558K Direct costs-HealthCare Patient Service$205,502K Selling, general andadministrative expense$105,574K (-2.09%↓ Y/Y)Depreciation andamortization$6,944K (10.45%↑ Y/Y)Direct costs-ClinicalResearch Trials And Other...$234K
Income Statement
source: myfinsight.com

Oncology Institute, Inc. (DFPH)

Oncology Institute, Inc. (DFPH)